SCHEMBL7561114

SCHEMBL7561114

CCCC(=O)c1ccc(Oc2ccc(C3CCNCC3OCc3ccc4ccccc4c3)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 19/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7440722 0.91 REN (0.60) REN
SCHEMBL6041636 0.85 REN (0.80) REN
SCHEMBL6042968 0.84 REN (1.00) REN
SCHEMBL6959162 0.84 REN (0.79) REN
Hydrochloric Acid SCHEMBL6042519 0.83 REN (0.77) REN
Hydrochloric Acid SCHEMBL27502164 0.83 REN (0.76) REN
SCHEMBL7560637 0.82 REN (0.63) REN
Trifluoroacetic Acid SCHEMBL6041901 0.81 REN (0.73) REN
SCHEMBL6951046 0.81 REN (0.78) REN
SCHEMBL27535962 0.81 REN (0.81) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076440-A2 METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES ELAN PHARMACEUTICALS, INC. (US) 2002-10-03 WO disclosed